dgMarket®
Tenders and consulting opportunities worldwide
Members: please log in
Alerts Subscription Help
       
 

UK-Reading: fertilisers and nitrogen compounds

Contract Award

General Information

Country:   United Kingdom
City/Locality:   READING
Notice/Contract Number:   eu:288241-2008
Publication Date:   Nov 7, 2008
Buyer:   NHS PURCHASING AND SUPPLY AGENCY
Original Language:   English

Contact Information

Address:   NHS PURCHASING AND SUPPLY AGENCY
READING , EAST OF ENGLAND  
United Kingdom
Web Site:   https://pasa.bravosolution.com

Goods, Works and Services

 

Original Text

     view in:

Notice Type: 2180
-
Contract award
Regulation of Procurement: European Communities, with participation by GPA countries
EU Official Journal Publication: 217/2008
, #
288241-2008
Referenced Document Number: 126877-2008
Contract Nature: Supply contract
Procedure Type: Contract awards
Type of Bid Required: Not applicable
Awarding Criteria: The most economic tender

Summary:
CONTRACT AWARD NOTICE
Supplies
SECTION I: CONTRACTING AUTHORITY
I.1) NAME, ADDRESSES AND CONTACT POINT(S): NHS Purchasing and Supply
Agency, Premier House, 60 Caversham Road, Attn: Emma Salter, UK-Reading
RG1 7EB. Tel. 011 89 80 86 00. E-mail: emma.salter@pasa.nhs.uk. Fax 011 89
80 86 50.
Internet address(es):
General address of the contracting authority:
https://pasa.bravosolution.com.
I.2) TYPE OF THE CONTRACTING AUTHORITY AND MAIN ACTIVITY OR ACTIVITIES:
Ministry or any other national or federal authority, including their
regional or local sub-divisions.
Health.
Other: Public Procurement.
The contracting authority is purchasing on behalf of other contracting
authorities: yes.
SECTION II: OBJECT OF THE CONTRACT
II.1) DESCRIPTION
II.1.1) Title attributed to the contract by the contracting authority:
East of England Therapeutic and Proprietary Pharmaceuticals.
II.1.2) Type of contract and location of works, place of delivery or of
performance: Supplies.
Purchase.
Main place of delivery: Trusts within the East of England Pharmacy
Purchasing Group.
NUTS code UKH.
II.1.4) Short description of the contract or purchase(s): Framework
agreement for the supply of Therapeutic and Proprietary Pharmaceuticals
for the East of England region. The Therapeutic proportion of this
framework will run for an initial term of one year to 31.10.2009. The
Proprietary products will have an initial contract term of two years,
ending 31.10.2010. Both products areas will have extension options,
details are given in section II.2.2.
II.1.5) Common procurement vocabulary (CPV): 24400000.
II.1.6) Contract covered by the Government Procurement Agreement (GPA):
Yes.
II.2) TOTAL FINAL VALUE OF CONTRACT(S)
II.2.1) Total final value of contract(s): Value: 10 140 000 GBP.
SECTION IV: PROCEDURE
IV.1) TYPE OF PROCEDURE
IV.1.1) Type of procedure: Restricted.
IV.2) AWARD CRITERIA
IV.2.1) Award criteria: The most economically advantageous tender in
terms of
1. Price.
2. Quality.
3. Market Risk.
4. Delivery Performance.
IV.2.2) An electronic auction was used: No.
IV.3) ADMINISTRATIVE INFORMATION
IV.3.1) File reference number attributed by the Contracting Authority:
CM/PHR/07/4758.
IV.3.2) Previous publication(s) concerning the same contract: Contract
notice
Notice number in OJ: 2008/S 93-126877 of 15.5.2008.
SECTION V: AWARD OF CONTRACT
V.1) DATE OF CONTRACT AWARD: 24.9.2008.
V.2) NUMBER OF OFFERS RECEIVED: 39.
SECTION VI: COMPLEMENTARY INFORMATION
VI.1) CONTRACT RELATED TO A PROJECT AND/OR PROGRAMME FINANCED BY
COMMUNITY FUNDS: No.
VI.2) ADDITIONAL INFORMATION: V: Award of Contract:
Framework has been awarded to Allergan Ltd, Amgen Ltd, Sanofi-Aventis,
Bristol-Myers Squibb Pharmaceuticals Limited, Cephalon Ltd, Chugai Pharma
UK Ltd, Eli Lilly ^ COmpany Limited, Ferring Pharmaceuticals Limited,
Genzyme Ltd, GlaxoSmithKline UK Ltd, Hospira UK Ltd, Ipsen Limited, Kent
Pharmaceuticals Ltd, Merck Pharmaceuticals, Merck Sharp & Dohme Ltd,
Novartis Pharmaceuticals UK Ltd, Pharmasure Ltd, Ranbaxy UK Limited,
Ratiopharm UK Ltd, Roche Products Ltd, Schering-Plough Ltd and Waymade
Healthcare plc.
The contract is for the benefit of other participating NHS bodies (whether
acting individually, or on behalf of, or together as members of any
consortia) along with any other non-NHS bodies which the participants deem
necessary for the delivery of services or goods to NHS bodies, local
authorities, other government departments or non-departmental public
bodies charged with the delivery of healthcare or health related services.
Contracts awarded under a framework agreement may be awarded either:
a) By application of the terms laid down in the framework agreement
without reopening competition, or,
b) Where not all the required terms of the proposed contracts are laid
down in the framework agreement, by reopening competition between the
economic operators which are parties to this framework agreement and which
are capable of performing the proposed contract. Reopening of competition
will be done in accordance with the procedure set out in Directive
2004/18/EC, Article 32.
The operation of the framework agreement will incorporate the reopening of
competition between the economic operators which are party to the
framework agreement so as to incorporate the effects of competition, and
the effect on competition, derived from beneficiaries of and parties to
the contracts under the Agreement to include central purchasing bodies as
detailed in Article 32 of Directive 2004/18/EC; Collaborative Purchasing
Hubs; Confederations; Purchasing Consortiums; Trusts and other
incorporated and un-incorporated bodies acting under the aegis of
aggregate purchasing policies, and/or volume commitment/exclusivity
commitment policies, and forms devolved to regional and local levels
within the UK National Health Service (NHS).
VI.3) PROCEDURES FOR APPEAL:
VI.3.2) Lodging of appeals: Precise information on deadline(s) for
lodging appeals: If an appeal regarding the award of a contract has not
been successfully resolved the Public Contracts Regulations 2006 (SI 2006
No 5) provide for aggrieved parties who have been harmed or are at risk of
harm by a breach of the rules to take action in the High Court (England,
Wales and Northern Ireland). Any such action must be brought promptly
(generally within 3 months). Where a contract has not been entered into
the Court may order the setting aside of the award decision or order the
authority to amend any document and may award damages. If the contract has
been entered into the Court may only award damages.
VI.4) DATE OF DISPATCH OF THIS NOTICE: 4.11.2008.


Please note that this notice is for your information only.
We try our best to have the most accurate and up-to-date information available on our web site, but we cannot guarantee that all of the information provided is error-free.
If you have any suggestions for updates/corrections for this notice, please let us know.








Bahasa Indonesia  Català  Deutsch  Eesti  English  Español  Français  Italiano  Polski  Português  Română  Tiếng Việt  Türkçe  Uzbek  Ελληνικά  Монгол  Русский  Հայերեն  اردو  عربي  ქართული  中文  日本語 
Partners Privacy Policy Procurement Regulations Terms and Conditions RSS Contact Us

dgMarket -  Tenders and consulting opportunities worldwide